Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 04, 2019

SELL
$6.16 - $9.6 $475,613 - $741,216
-77,210 Closed
0 $0
Q1 2019

Apr 05, 2019

SELL
$15.58 - $20.01 $327 - $420
-21 Reduced 0.03%
77,210 $1.21 Million
Q4 2018

Jan 09, 2019

SELL
$14.59 - $23.84 $2,290 - $3,742
-157 Reduced 0.2%
77,231 $1.19 Million
Q3 2018

Oct 05, 2018

SELL
$21.06 - $25.65 $863 - $1,051
-41 Reduced 0.05%
77,388 $1.67 Million
Q2 2018

Jul 09, 2018

SELL
$16.77 - $24.71 $452 - $667
-27 Reduced 0.03%
77,429 $1.88 Million
Q1 2018

Apr 06, 2018

BUY
$16.68 - $22.07 $4,536 - $6,003
272 Added 0.35%
77,456 $1.32 Million
Q4 2017

Jan 09, 2018

SELL
$11.23 - $19.1 $1.48 Million - $2.52 Million
-131,773 Reduced 63.06%
77,184 $1.46 Million
Q3 2017

Oct 10, 2017

BUY
$15.41 - $32.17 $3.22 Million - $6.72 Million
208,957
208,957 $3.68 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Kempner Capital Management Inc. Portfolio

Follow Kempner Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kempner Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kempner Capital Management Inc. with notifications on news.